NASDAQ : PHIO
Phio Pharmaceuticals Corp. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.8626 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 10.02M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cost of Revenue | 8.53M | 4.62M | 3.64M | 6.33M | 7.01M | 8.89M |
| Gross Profit | -8.53M | -4.62M | -3.64M | -6.33M | -7.01M | -8.89M |
| Selling, General & Admin | 4.94M | 4.60M | 3.74M | 4.37M | 4.45M | 4.62M |
| Operating Expenses | 4.94M | 4.60M | 3.74M | 4.37M | 4.45M | 4.62M |
| Operating Income | -13.47M | -9.22M | -7.39M | -10.70M | -11.46M | -13.51M |
| Interest Expense | -8.00K | |||||
| Interest & Investment Income | 565.00K | 520.00K | 231.00K | |||
| Other Non Operating Income (Expenses) | 5.00K | 2.00K | 6.00K | 6.00K | -18.00K | -9.00K |
| EBT Excluding Unusual Items | -12.90M | -8.70M | -7.15M | -10.70M | -11.48M | -13.52M |
| Asset Writedown | -126.00K | |||||
| Other Unusual Items | 233.00K | |||||
| Pretax Income | -12.90M | -8.70M | -7.15M | -10.83M | -11.48M | -13.29M |
| Net Income | -12.90M | -8.70M | -7.15M | -10.83M | -11.48M | -13.29M |
| Net Income to Common | -12.90M | -8.70M | -7.15M | -10.83M | -11.48M | -13.29M |
| Shares Outstanding (Basic) | 9.52M | 5.98M | 787.47K | 231.51K | 126.28K | 118.80K |
| Shares Outstanding (Diluted) | 9.52M | 5.98M | 787.47K | 231.51K | 126.28K | 118.80K |
| EPS (Basic) | -1.36 | -1.45 | -9.08 | -46.76 | -90.91 | -111.84 |
| EPS (Diluted) | -1.36 | -1.45 | -9.08 | -46.76 | -90.91 | -111.87 |
| Free Cash Flow | -12.21M | -7.99M | -7.11M | -10.75M | -12.25M | -11.91M |
| Free Cash Flow Per Share | -1.28 | -1.33 | -9.03 | -46.45 | -97.00 | -100.24 |
| EBITDA | -13.47M | -9.22M | -7.38M | -10.64M | -11.39M | -13.44M |
| D&A For EBITDA | 4.00K | 3.00K | 2.00K | 56.00K | 71.00K | 75.00K |
| EBIT | -13.47M | -9.22M | -7.39M | -10.70M | -11.46M | -13.51M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 13.00M | 21.03M | 5.38M | 8.49M | 11.78M | 24.06M |
| Cash & Short-Term Investments | 13.00M | 21.03M | 5.38M | 8.49M | 11.78M | 24.06M |
| Prepaid Expenses | 1.30M | 445.00K | 354.00K | 832.00K | 615.00K | 620.00K |
| Restricted Cash | 50.00K | 50.00K | ||||
| Total Current Assets | 14.30M | 21.48M | 5.74M | 9.32M | 12.45M | 24.73M |
| Property, Plant & Equipment | 9.00K | 11.00K | 2.00K | 39.00K | 344.00K | 416.00K |
| Other Long-Term Assets | 3.00K | 24.00K | 27.00K | |||
| Total Assets | 14.31M | 21.49M | 5.74M | 9.36M | 12.81M | 25.17M |
| Accounts Payable | 901.00K | 435.00K | 253.00K | 657.00K | 779.00K | 283.00K |
| Accrued Expenses | 804.00K | 905.00K | 762.00K | 942.00K | 1.01M | 2.66M |
| Current Portion of Leases | 35.00K | 135.00K | 125.00K | |||
| Other Current Liabilities | 19.00K | |||||
| Total Current Liabilities | 1.71M | 1.34M | 1.01M | 1.63M | 1.94M | 3.07M |
| Long-Term Leases | 35.00K | 170.00K | ||||
| Total Liabilities | 1.71M | 1.34M | 1.01M | 1.63M | 1.97M | 3.24M |
| Common Stock | 1.00K | 1.00K | ||||
| Additional Paid-In Capital | 175.80M | 175.20M | 151.08M | 146.94M | 139.22M | 138.83M |
| Retained Earnings | -163.19M | -155.05M | -146.36M | -139.21M | -128.38M | -116.90M |
| Total Common Equity | 12.60M | 20.15M | 4.72M | 7.73M | 10.84M | 21.93M |
| Shareholders' Equity | 12.60M | 20.15M | 4.72M | 7.73M | 10.84M | 21.93M |
| Total Liabilities & Equity | 14.31M | 21.49M | 5.74M | 9.36M | 12.81M | 25.17M |
| Total Debt | 35.00K | 170.00K | 295.00K | |||
| Net Cash (Debt) | 13.00M | 21.03M | 5.38M | 8.46M | 11.61M | 23.76M |
| Net Cash Per Share | 1.37 | 3.51 | 6.83 | 36.52 | 91.94 | 200.01 |
| Filing Date Shares Outstanding | 11.62M | 11.62M | 4.78M | 510.19K | 127.84K | 125.32K |
| Total Common Shares Outstanding | 11.62M | 11.62M | 1.73M | 416.37K | 126.56K | 125.32K |
| Working Capital | 12.59M | 20.14M | 4.72M | 7.69M | 10.51M | 21.66M |
| Book Value Per Share | 1.08 | 1.73 | 2.72 | 18.57 | 85.64 | 175.00 |
| Tangible Book Value | 12.60M | 20.15M | 4.72M | 7.73M | 10.84M | 21.93M |
| Tangible Book Value Per Share | 1.08 | 1.73 | 2.72 | 18.57 | 85.64 | 175.00 |
| Machinery | 239.00K | 308.00K | 1.10M | 1.31M | 1.19M | |
| Leasehold Improvements | 46.00K | 46.00K | 46.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -12.90M | -8.70M | -7.15M | -10.83M | -11.48M | -13.29M |
| Depreciation & Amortization | 5.00K | 3.00K | 35.00K | 184.00K | 193.00K | 192.00K |
| Loss (Gain) From Sale of Assets | -3.00K | -6.00K | ||||
| Asset Writedown & Restructuring Costs | 126.00K | |||||
| Stock-Based Compensation | 983.00K | 481.00K | 147.00K | 303.00K | 414.00K | 480.00K |
| Other Operating Activities | -233.00K | |||||
| Change in Accounts Payable | 667.00K | 183.00K | -404.00K | -122.00K | 496.00K | -445.00K |
| Change in Other Net Operating Assets | -950.00K | 52.00K | 266.00K | -414.00K | -1.75M | 1.44M |
| Operating Cash Flow | -12.20M | -7.98M | -7.11M | -10.75M | -12.13M | -11.86M |
| Capital Expenditures | -7.00K | -12.00K | -1.00K | -5.00K | -121.00K | -51.00K |
| Sale of Property, Plant & Equipment | 3.00K | 9.00K | ||||
| Investing Cash Flow | -4.00K | -12.00K | 8.00K | -5.00K | -121.00K | -51.00K |
| Issuance of Common Stock | 14.46M | 23.67M | 4.00M | 7.45M | 21.72M | |
| Repurchase of Common Stock | -30.00K | -30.00K | -6.00K | -37.00K | -28.00K | -1.00K |
| Financing Cash Flow | 14.43M | 23.64M | 4.00M | 7.41M | -26.00K | 21.72M |
| Net Cash Flow | 2.22M | 15.65M | -3.11M | -3.34M | -12.28M | 9.81M |
| Free Cash Flow | -12.21M | -7.99M | -7.11M | -10.75M | -12.25M | -11.91M |
| Free Cash Flow Per Share | -1.28 | -1.33 | -9.03 | -46.45 | -97.00 | -100.24 |
| Levered Free Cash Flow | -7.72M | -5.06M | -4.54M | -6.58M | -7.81M | -6.71M |
| Unlevered Free Cash Flow | -7.72M | -5.06M | -4.54M | -6.58M | -7.81M | -6.71M |
| Cash Interest Paid | 13.00K | 11.00K | ||||
| Change in Working Capital | -283.00K | 235.00K | -138.00K | -536.00K | -1.26M | 990.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 10.22M | 11.30M | 3.12M | 1.86M | 5.08M | 13.53M |
| Enterprise Value | -2.77M | 597.65K | -2.27M | -6.48M | -9.20M | -12.68M |
| Last Close Price | 0.88 | 1.05 | 1.80 | 6.84 | 40.18 | 108.00 |
| Forward PE | 0.43 | 0.13 | 0.21 | 0.37 | 2.19 | |
| PB Ratio | 0.81 | 0.56 | 0.66 | 0.24 | 0.47 | 0.62 |
| P/TBV Ratio | 0.81 | 0.56 | 0.66 | 0.24 | 0.47 | 0.62 |
| Debt / Equity Ratio | 0.01 | 0.02 | 0.01 | |||
| Net Debt / Equity Ratio | -1.03 | -1.04 | -1.14 | -1.09 | -1.07 | -1.08 |
| Net Debt / EBITDA Ratio | 0.96 | 2.28 | 0.73 | 0.79 | 1.02 | 1.77 |
| Net Debt / FCF Ratio | 1.06 | 2.63 | 0.76 | 0.79 | 0.95 | 2.00 |
| Quick Ratio | 7.62 | 15.70 | 5.30 | 5.20 | 6.08 | 7.84 |
| Current Ratio | 8.39 | 16.03 | 5.65 | 5.71 | 6.42 | 8.06 |
| Return on Equity (ROE) | -113.71% | -69.95% | -114.83% | -116.60% | -70.06% | -76.04% |
| Return on Assets (ROA) | -65.77% | -42.33% | -61.14% | -60.30% | -37.72% | -41.28% |
| Return on Capital Employed (ROCE) | -106.90% | -45.80% | -156.40% | -138.40% | -105.40% | -61.10% |
| Earnings Yield | -154.08% | -76.95% | -229.29% | -582.98% | -225.78% | -98.17% |
| FCF Yield | -119.42% | -70.70% | -228.10% | -579.10% | -240.93% | -87.99% |
| Buyback Yield / Dilution | -238.90% | -659.91% | -240.15% | -83.32% | -6.30% | -179.70% |